全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Translation, Cross-Cultural Adaptation, and Validation of the Parkinson's Disease Quality of Life Questionnaire (PDQL), the “PDQL-BR”, into Brazilian Portuguese

DOI: 10.5402/2011/954787

Full-Text   Cite this paper   Add to My Lib

Abstract:

Translate, culturally adapt, and validate the “Parkinson's Disease Quality of Life” (PDQL) BR, into Brazilian Portuguese. Fifty-two patients answered the PDQL-BR. Twenty-one patients answered the PDQL-BR again 14 days later. The UPDRS and HY scale was applied. Validation was evaluated using psychometric properties, checking the quality of the data, reliability, and validity. Quality of the data was evaluated based on occurrence of ceiling and floor effects. Reliability was evaluated based on: internal consistency of an item, homogeneity, and reproducibility. Validation was checked through the evaluation of convergent and discriminatory validation. There was no ceiling and floor effect. When evaluating reliability, items 20, 30, and 37 showed correlation of 0.34, 0.26, and 0.37, respectively, to your scale; the other items was higher than 0.4. The alpha Cronbach coefficient was higher than 0.7 for most domains. There was good reproducibility. There were no meaningful changes in the PDQL-BR translation and cross-cultural adaptation. 1. Introduction Parkinson’s disease (PD) is a neurodegenerative disease characterized by the occurrence of motor and nonmotor symptoms. Motor symptoms include arrest tremors, stiffness, bradykinesia, and instabilities in posture and gait. Nonmotor symptoms include autonomic dysfunctions that result in changes in blood pressure control and intestinal function. The disease shows an inevitably progressive course and an increasing number of other symptoms. Frequently, Parkinson’s disease patients go through periods of depression and dementia. In more advanced stages, complications caused by treatment with dopaminergic drugs result in fluctuations in motor function [1]. The symptoms, comorbidities, and complications of treatment restrict the autonomy and the welfare of affected individuals, leading to prejudices in their professional, social, and emotional lives [2]. In order to evaluate multidimensional features such as those described above, recently special attention has been given to evaluating the quality of life (QL) and, more specifically the perception of welfare in light of the state of the patient health, which has lead to the development of the Health-Related Quality of Life (HRQL) surveys [3]. The development of the HRQL has allowed health care providers to determine a better approach to caring for the patient; the HRQL also places more value on considering the needs and the expectations of the patient and provides a comparison among different groups [3]. The HRQL instruments are divided into two groups: generic and

References

[1]  N. Yanagisawa, “Natural history of Parkinson's disease: from dopamine to multiple system involvement,” Parkinsonism and Related Disorders, vol. 12, no. 2, pp. S40–S46, 2006.
[2]  P. Hobson, A. Holden, and J. Meara, “Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire,” Age and Ageing, vol. 28, no. 4, pp. 341–346, 1999.
[3]  W. Kuyken, “The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization,” Social Science and Medicine, vol. 41, no. 10, pp. 1403–1409, 1995.
[4]  G. H. Guyatt, D. H. Feeny, and D. L. Patrick, “Measuring health-related quality of life,” Annals of Internal Medicine, vol. 118, no. 8, pp. 622–629, 1993.
[5]  J. Marinus, C. Ramaker, J. J. van Hilten, and A. M. Stiggelbout, “Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 2, pp. 241–248, 2002.
[6]  E. D. Pe?a, “Lost in translation: methodological considerations in cross-cultural research,” Child Development, vol. 78, no. 4, pp. 1255–1264, 2007.
[7]  F. Guillemin, C. Bombardier, and D. Beaton, “Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines,” Journal of Clinical Epidemiology, vol. 46, no. 12, pp. 1417–1432, 1993.
[8]  http://www.mapi -trust.org/.
[9]  A. G. E. M. De Boer, W. Wijker, J. D. Speelman, and J. C. J. M. De Haes, “Quality of life in patients with Parkinson's disease: development of a questionnaire,” Journal of Neurology Neurosurgery and Psychiatry, vol. 61, no. 1, pp. 70–74, 1996.
[10]  M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini mental state”. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975.
[11]  M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967.
[12]  C. G. Goetz, “The unified Parkinson's disease rating scale (UPDRS): status and recommendations,” Movement Disorders, vol. 18, no. 7, pp. 738–750, 2003.
[13]  A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaug, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, pp. 561–571, 1961.
[14]  K. N. Lohr, “Health outcomes methodology symposium: summary and recommendations,” Medical Care, vol. 38, supplement 9, pp. 194–208, 2000.
[15]  C. A. McHorney, J. E. Ware, and A. E. Raczek, “The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs,” Medical Care, vol. 31, no. 3, pp. 247–263, 1993.
[16]  G. H. Guyatt, C. D. Naylor, E. Juniper, D. K. Heyland, R. Jaeschke, and D. J. Cook, “Users' guides to the medical literature: XII. How to use articles about health-related quality of life,” Journal of the American Medical Association, vol. 277, no. 15, pp. 1232–1237, 1997.
[17]  M. Reuther, E. A. Spottke, J. Klotsche et al., “Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study,” Parkinsonism and Related Disorders, vol. 13, no. 2, pp. 108–114, 2007.
[18]  M. Behari, A. K. Srivastava, and R. M. Pandey, “Quality of life in patients with Parkinson's disease,” Parkinsonism and Related Disorders, vol. 11, no. 4, pp. 221–226, 2005.
[19]  M. Serrano-Due?as, P. Martínez-Martín, and V. Vaca-Baquero, “Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV),” Parkinsonism and Related Disorders, vol. 10, no. 7, pp. 433–437, 2004.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133